Literature DB >> 17590178

An animal model to study lower urinary tract symptoms and erectile dysfunction: the hyperlipidaemic rat.

Nadeem U Rahman1, Surat Phonsombat, Derek Bochinski, Rafael E Carrion, Lora Nunes, Tom F Lue.   

Abstract

OBJECTIVE: To present evidence that rats fed a high-fat diet could serve as a useful animal model to study both lower urinary tract symptoms (LUTS) and erectile dysfunction (ED), as recent epidemiological studies have shown a strong association between LUTS and ED but the physiological basis behind this relationship is unknown.
MATERIALS AND METHODS: In all, 24 male Sprague-Dawley rats were divided into two groups: nine controls were fed a 'normal' diet and 15 were fed a high-fat diet (hyperlipidaemic rats). After 6 months all the rats had bladder and erectile functions evaluated using awake cystometry and cavernosal nerve electrostimulation, respectively. After the functional studies were completed, the penis, prostate and bladder were collected for immunohistochemical analysis.
RESULTS: The hyperlipidaemic rats had significantly higher serum cholesterol and low-density lipoprotein than the controls (P < 0.05). The hyperlipidaemic rats also had significantly worse erectile function (P = 0.004) and developed more bladder overactivity (P = 0.004) than the controls. In the hyperlipidaemic rats there was significant muscle hypertrophy in the peri-urethral lobe of the prostate (P < 0.001) and in the bladder (P < 0.05). There was also greater P2X(1) (purinoceptor) staining as well as other molecular changes in the bladder of the hyperlipidaemic rats.
CONCLUSIONS: In this hyperlipidaemic rat model three abnormalities were consistently detected: prostatic enlargement, bladder overactivity, and ED. This rat model could be a useful research tool for understanding the common causes of LUTS and ED, as well as facilitating the development of preventive measures and better therapies to treat both conditions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17590178     DOI: 10.1111/j.1464-410X.2007.07069.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  31 in total

1.  Pioglitazone attenuates prostatic enlargement in diet-induced insulin-resistant rats by altering lipid distribution and hyperinsulinaemia.

Authors:  Ajit Vikram; Gopabandhu Jena; Poduri Ramarao
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

Review 2.  [Primary and secondary prevention of benign prostatic hyperplasia: current knowledge and implications for clinical management].

Authors:  M Oelke; S Madersbacher
Journal:  Urologe A       Date:  2011-10       Impact factor: 0.639

3.  Metabolic syndrome and BPH: What do we know?

Authors:  Amit Agrawal
Journal:  Med J Armed Forces India       Date:  2017-01-07

4.  Urodynamic effects of once-daily tadalafil in men with LUTS secondary to clinical BPH.

Authors:  Alex Gomelsky; Roger R Dmochowski
Journal:  Curr Urol Rep       Date:  2010-07       Impact factor: 3.092

5.  Treatment of obesity-associated overactive bladder by the phosphodiesterase type-4 inhibitor roflumilast.

Authors:  Honglin Ding; Ning Li; Xiaoning He; Bing Liu; Liming Dong; Yili Liu
Journal:  Int Urol Nephrol       Date:  2017-07-29       Impact factor: 2.370

6.  Does hypercholesterolemia affect the relaxation of the detrusor smooth muscle in rats? In vitro and in vivo studies.

Authors:  Sibel Bayrak; Zeynep Dicle Balkanci; Bilge Pehlivanoğlu; İsmail Karabulut; Serkan Karaismailoğlu; Ayşen Erdem
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-10-26       Impact factor: 3.000

7.  Labeling and tracking of mesenchymal stromal cells with EdU.

Authors:  Guiting Lin; Yun-Ching Huang; Alan W Shindel; Lia Banie; Guifang Wang; Tom F Lue; Ching-Shwun Lin
Journal:  Cytotherapy       Date:  2009       Impact factor: 5.414

8.  Update on Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia.

Authors:  Dean S Elterman; Bilal Chughtai; Richard K Lee; Alexis E Te; Steven A Kaplan
Journal:  Rev Urol       Date:  2012

9.  Dietary macronutrients, cholesterol, and sodium and lower urinary tract symptoms in men.

Authors:  Nancy Nairi Maserejian; Edward L Giovannucci; John B McKinlay
Journal:  Eur Urol       Date:  2008-08-03       Impact factor: 20.096

10.  Adipose derived stem cells ameliorate hyperlipidemia associated detrusor overactivity in a rat model.

Authors:  Yun-Ching Huang; Alan W Shindel; Hongxiu Ning; Guiting Lin; Ahmed M Harraz; Guifang Wang; Maurice Garcia; Tom F Lue; Ching-Shwun Lin
Journal:  J Urol       Date:  2010-01-22       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.